Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cardiac afterload is a term describing the pressure or resistance that the heart, particularly the left ventricle, must overcome to eject blood into the aorta during systole. It is primarily determined by systemic vascular resistance and aortic pressure for the left heart, and pulmonary artery pressure for the right heart. Quantitatively, afterload can be estimated using formulas derived from the Law of Laplace, involving ventricular wall stress, chamber radius, and wall thickness. Physiologically, increased afterload reduces stroke volume and cardiac output, and persistent elevation contributes to pathological cardiac hypertrophy and heart failure. Afterload is not a molecular or pharmacological target itself, but it is influenced by various drugs used in the management of cardiovascular diseases, mainly by reducing vascular resistance.
Drugs affecting afterload generally act by decreasing systemic vascular resistance or reducing aortic/pulmonary pressure, thereby lowering the "load" the heart must overcome to eject blood
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cardiac afterload (null).